Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA methylation changes in multiple myeloma.

O Galm1, S Wilop, J Reichelt

  • 1Medizinische Klinik IV, Universitaetsklinikum Aachen, 52074 Aachen, Germany. oliver.galm@post.rwth-aachen.de

Leukemia
|August 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.

Oncogene·2026
Same author

Care of pregnant women with pre-existing medical conditions in German perinatal centers.

Archives of gynecology and obstetrics·2025
Same author

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.

World journal of urology·2022
Same author

Advancing novel therapies for ichthyoses.

The British journal of dermatology·2020
Same author

Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis.

Current research in translational medicine·2020
Same author

An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.

The British journal of dermatology·2018
Same journal

Linperlisib enhances MUC1-Tn CAR T cell efficacy by inhibiting EGR1/DUSP2 axis to prevent CAR T cell exhaustion.

Leukemia·2026
Same journal

CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia.

Leukemia·2026
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
See all related articles

Aberrant methylation of tumor suppressor genes is common in multiple myeloma (MM). Hypermethylation of specific genes like p16 correlates with poorer prognosis and may play a role in plasma cell disorder development.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Multiple myeloma (MM) is a malignant plasma cell disorder.
  • Tumor suppressor genes (TSGs) are critical in preventing cancer development.
  • Epigenetic alterations, such as DNA methylation, can silence TSGs.

Purpose of the Study:

  • To investigate the promoter-associated CpG island methylation status of 11 TSGs in MM.
  • To determine the frequency of aberrant methylation in MM cell lines and patient samples.
  • To explore the correlation between methylation patterns and clinical characteristics in MM.

Main Methods:

  • Candidate gene approach analyzing 11 well-characterized TSGs.
  • Methylation-specific polymerase chain reaction (MS-PCR).

Related Experiment Videos

  • Analysis in five MM cell lines and 56 primary patient samples.

    • Main Results:

    • At least one hypermethylated gene was found in 80.4% of patient samples; 33.9% had two or more.
    • Aberrant methylation frequencies: SOCS-1 (46.4%), p16 (35.7%), E-cadherin (21.4%), DAP kinase/p73 (12.5%), p15/MGMT/RARbeta (1.8%).
    • p73 hypermethylation identified in MM for the first time; p16 hypermethylation linked to poorer prognosis.

    Conclusions:

    • Aberrant methylation of TSGs is a frequent event in malignant plasma cell disorders.
    • Specific methylation patterns, including p73, are implicated in MM pathogenesis.
    • Methylation status correlates with clinical characteristics and prognosis in MM patients.